Murine leukemia retroviruses;Les rétrovirus leucémogènes murins: Pathogènes, gènes et outils génétiques

Virologie

Volumn 5, Issue 4, 2001, Pages 265-293

  Sitbon, M ^a   Denesvre, C ^a   Dardalhon, V ^a   Battini, J L ^a   Mougel, M ^a  

^a INSTITUT DE GÉNÉTIQUE MOLÉCULAIRE DE MONTPELLIER   (France)

Author keywords

Detection assay; MLV; Pathogenesis; Retroviral replication; Retroviral vector

Indexed keywords

VIRUS DNA; VIRUS RNA; VIRUS VECTOR;

CELL DIFFERENTIATION; GENE EXPRESSION; GENE THERAPY; HUMAN; MURINE LEUKEMIA VIRUS; NONHUMAN; PATHOGENESIS; PROVIRUS; REVIEW; VIRAL GENETICS; VIRUS CAPSID; VIRUS INFECTION; VIRUS NUCLEOCAPSID; VIRUS REPLICATION; VIRUS TRANSMISSION;

DNA VIRUSES; EUKARYOTA; MIRIDAE; MURINAE; MURINE LEUKEMIA VIRUS; RNA VIRUSES;

EID: 18344406148     PISSN: 12678694     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (106)

1. Characterization of monoclonal antibodies reactive with murine leukemia viruses: Use in analysis of strains of Friend MCF and Friend ecotropic murine leukemia virus
2. Effect of murine host genotype on MCF virus expression, latency, and leukemia cell type of leukemias induced by Friend murine leukemia helper virus
3. A small region of the ecotropic murine leukemia virus (MuLV) gag gene profoundly influences the types of polytropic MuLVs generated in mice
4. Sequence analysis of amphotropic and 10A1 murine leukemia viruses: Close relationship to mink cell focus-inducing viruses
5. Molecular cloning of Mus dunni endogenous virus: An unusual retrovirus in a new murine viral interference group with a wide host range
6. Initial binding of murine leukemia virus particles to cells does not require specific Env-receptor interaction
7. Modulation of phosphate uptake and amphotropic murine leukemia virus entry by posttranslational modifications of PIT-2
8. Characterization of intracellular reverse transcription complexes of Moloney murine leukemia virus
9. Impairment of Moloney murine leukemia virus integration in a cell line underexpressing DNA topoisomerase II
10. A role for DNA-PK in retroviral DNA integration
11. Threshold number of provirus copies required per cell for efficient virus production and interference in Moloney murine leukemia virus-infected NIH 3T3 cells
12. Moloney murine leukemia virus long terminal repeat activates monocyte chemotactic protein-1 protein expression and chemotactic activity
13. A transcript from the long terminal repeats of a murine retrovirus associated with trans activation of cellular genes
14. A novel subgenomic murine leukemia virus RNA transcript results from alternative splicing
15. Contribution of oncogenes and tumor suppressor genes to myeloid leukemia
16. Cis-active structural motifs involved in specific encapsidation of Moloney murine leukemia virus RNA
17. Avian retroviral RNA element promotes unspliced RNA accumulation in the cytoplasm
18. A small element from the Mason-Pfizer monkey virus genome makes human immunodeficiency virus type 1 expression and replication Rev-independent
19. Region sequences in the long terminal repeat of a murine retrovirus specifically increase expression of unspliced RNAs
20. The extended packaging sequence of MoMLV contains a constitutive mRNA nuclear export function
21. An internal ribosomal entry mechanism promotes translation of murine leukemia virus Gag polyprotein precursors
22. Alternative translation initiation of the Moloney murine leukemia virus mRNA controlled by internal ribosome entry involving the p57/PTB splicing factor
23. CUG initiation codon used for the synthesis of a cell surface antigen coded by the murine leukemia virus
24. A nonstructural gag-encoded glycoprotein precursor is necessary for efficient spreading and pathogenesis of murine leukemia viruses
25. Identification of a sequence in the unique 5′ open reading frame of the gene encoding glycosylated Gag which influences the incubation period of neurodegenerative disease induced by a murine retrovirus
26. The neuroinvasiveness of a murine retrovirus is influenced by a dileucine-containing sequence in the cytoplasmic tail of glycosylated Gag
27. Retrovirus envelope glycoproteins
28. Transport and assembly of Gag proteins into Moloney murine leukemia virus
29. First glimpses at structure-function relationships of the nucleocapsid protein of retroviruses
30. Effect of dimerization on the conformation of the encapsidation Psi domain of Moloney murine leukemia virus RNA
31. A short autocomplementary sequence in the 5′ leader region is responsible for dimerization of MoMuLV genomic RNA
32. Dimerization of MoMuLV genomic RNA: Redefinition of the role of the palindromic stem-loop H1 (278-303) and new roles for stem-loops H2 (310-352) and H3 (355-374)
33. A role for two hairpin structures as a core RNA encapsidation signal in murine leukemia virus virions
34. Nucleic-acid-chaperone activity of retroviral nucleocapsid proteins: Significance for viral replication
35. Genetic control of sensitivity to Moloney leukemia virus in mice. II. Mapping of three resistant genes within the H-2 complex
36. Increased expression of MIP-1alpha and MIP-1beta mRNAs in the brain correlates spatially and temporally with the spongiform neurodegeneration induced by a murine oncornavirus
37. Receptor choice determinants in the envelope glycoproteins of amphotropic, xenotropic, and polytropic murine leukemia viruses
38. Structure of a murine leukemia virus receptor-binding glycoprotein at 2.0 angstrom resolution
39. Effects of subtle changes in the SU protein of ecotropic murine leukemia virus on its brain capillary endothelial cell tropism and interference properties
40. Induction of syncytia by neuropathogenic murine leukemia viruses depends on receptor density, host cell determinants, and the intrinsic fusion potential of envelope protein
41. A proline-rich motif downstream of the receptor binding domain modulates conformation and fusogenicity of murine retroviral envelopes
42. Substitution of leucine for isoleucine in a sequence highly conserved among retroviral envelope surface glycoproteins attenuates the lytic effect of the Friend murine leukemia virus
43. Localization of the labile disulfide bond between SU and TM of the murine leukemia virus envelope protein complex to a highly conserved CWLC motif in SU that resembles the active-site sequence of thiol-disulfide exchange enzymes
44. Activation of membrane fusion by murine leukemia viruses is controlled in cis or in trans by interactions between the receptor-binding domain and a conserved disulfide loop of the carboxy terminus of the surface glycoprotein
45. Definition of an amino-terminal domain of the human T-cell leukemia virus type 1 envelope surface unit that extends the fusogenic range of an ecotropic murine leukemia virus
46. Different recombinant murine leukemia viruses use different cell surface receptors
47. Cell-surface receptors for retroviruses and implications for gene transfer
48. A human cell-surface receptor for xenotropic and polytropic murine leukemia viruses: Possible role in G protein-coupled signal transduction
49. Polymorphisms of the cell surface receptor control mouse susceptibilities to xenotropic and polytropic leukemia viruses
50. The Fv-1 gene of the mouse and its control of murine leukemia virus replication
51. Single amino acid changes in the murine leukemia virus capsid protein gene define the target of Fv1 resistance
52. Fv-1 restriction and its effects on murine leukemia virus integration in vivo and in vitro
53. Alleviation of murine leukemia virus repression in embryonic carcinoma cells by genetically engineered primer binding sites and artificial tRNA primers
54. Host cis-mediated extinction of a retrovirus permissive for expression in embryonal stem cells during differentiation
55. Studies on the restriction of ecotropic murine retrovirus replication in mouse teratocarcinoma cells
56. Tissue-specific replication of Friend and Moloney murine leukemia viruses in infected mice
57. Identification of directly infected cells in the bone marrow of neonatal moloney murine leukemia virus-infected mice by use of a Moloney murine leukemia virus-based vector
58. Introduction of a cis-acting mutation in the capsid-coding gene of Moloney murine leukemia virus extends its leukemogenic properties
59. Age-dependent resistance to murine retrovirus-induced spongiform neurodegeneration results from central nervous system-specific restriction of virus replication
60. Moloney murine leukemia virus infects cells of the developing hair follicle after neonatal subcutaneous inoculation in mice
61. Tumorigenesis by slow-transforming retroviruses-an update
62. Leukemogenesis by Moloney murine leukemia virus: A multistep process
63. Early involvement of the fim-2 and fim-3 regions in mouse myeloblastic leukemogenesis
64. Mutation of the core or adjacent LVb elements of the Moloney murine leukemia virus enhancer alters disease specificity
65. A 3′ end fragment encompassing the transcriptional enhancer of non-defective Friend virus confers erythroleukemogenicity on Moloney murine leukemia virus
66. Oncogene activation in myeloid leukemias by Graffi murine leukemia virus proviral integration
67. Erythroleukemia induction by Friend murine leukemia virus: Insertional activation of a new member of the ets gene family, Fli-1, closely linked to c-ets-1
68. Friend murine leukaemia virus is integrated at a common site in most primary spleen tumours of erythroleukaemic animals
69. Dissecting the determinants of neuropathogenesis of the murine oncornaviruses
70. The Lake Casitas wild mouse: Evolving genetic resistance to retroviral disease
71. Murine leukemia virus induced central nervous system diseases
72. Murine retrovirus-induced spongiform encephalopathy: Productive infection of microglia and cerebellar neurons in accelerated CNS disease
73. Brain infection by neuroinvasive but avirulent murine oncornaviruses
74. A Val-25-to-Ile substitution in the envelope precursor polyprotein, gPr80env, is responsible for the temperature sensitivity, inefficient processing of gPr80env, and neurovirulence of ts1, a mutant of Moloney murine leukemia virus TB
75. Hemolytic anemia and erythroleukemia, two distinct pathogenic effects of Friend MuLV: Mapping of the effects to different regions of the viral genome
76. Sequences responsible for the distinctive hemolytic potentials of Friend and Moloney murine leukemia viruses are dispersed but confined to the Ψ-gag-PR region
77. Identification of genetic determinants responsible for the rapid immunosuppressive activity and the low leukemogenic potential of a variant of Friend leukemia virus, FIS-2
78. Host genetic control of spontaneous and induced immunity to Friend murine retrovirus infection
79. Molecular phylogeny of Fv1
80. Positional cloning of the mouse retrovirus restriction gene Fv1
81. Cloning of a new murine endogenous retrovirus, MuERV-L, with strong similarity to the human HERV-L element and with a gag coding sequence closely related to the Fv1 restriction gene
82. A conserved mechanism of retrovirus restriction in mammals
83. Fv-4: Gene controlling resistance to NB-tropic Friend murine leukemia virus. Distribution in wild mice, introduction into genetic background of BALB/c mice, and mapping of chromosomes
84. Transgenic Fv-4 mice resistant to Friend virus
85. Interférence à la surinfection: Un mécanisme non immunitaire de vaccination contre les maladies rétrovirales
86. A mouse gene on chromosome 5 that restricts infectivity of mink cell focus-forming recombinant murine leukemia viruses
87. Sensitization of cells and retroviruses to human serum by (alpha 1-3) galactosyltransferase
88. Tunicamycin treatment of CHO cells abrogates multiple blocks to retrovirus infection, one of which is due to a secreted inhibitor
89. Safe and efficient generation of recombinant retroviruses with amphotropic and ecotropic host ranges
90. Improved retroviral vectors for gene transfer and expression
91. Increased levels of spliced RNA account for augmented expression from the MFG retroviral vector in hematopoietic cells
92. Effects of retroviral vector design on expression of human adenosine deaminase in murine bone marrow transplant recipients engrafted with genetically modified cells
93. Gene therapy of human severe combined immunodeficiency (SCID)-XI disease
94. Multiple modifications in cis elements of the long terminal repeat of retroviral vectors lead to increased expression and decreased DNA methylation in embryonic carcinoma cells
95. Isolation of a recombinant murine leukemia virus utilizing a new primer tRNA
96. Efficient transduction of hemopoietic CD34+ progenitors of human origin using an original retroviral vector derived from Fr-MuLV-FB29: In vitro assessment
97. Retroviral vector-mediated gene expression in human CD34+CD38- cells expanded in vitro: Cis elements of FMEV are superior to those of Mo-MuLV
98. T cell-specific expression from Mo-MLV retroviral vectors containing a CD4 mini-promoter/enhancer
99. Construction of retroviral vectors with improved safety, gene expression, and versatility
100. High-titer packaging cells producing recombinant retroviruses resistant to human serum
101. Episomal vectors rapidly and stably produce high-titer recombinant retrovirus
102. The pCL vector system: Rapid production of helper-free, high-titer, recombinant retroviruses
103. Modifying the host range properties of retroviral vectors
104. In vitro analysis of transformation potential associated with retroviral vector insertions
105. Use of a focal immunofluorescence assay on live cells for quantitation of retroviruses: Distinction of host range classes in virus mixtures and biological cloning of dual-tropic murine leukemia viruses